Why It Matters?

It is crucial to include Arab ethnicities in clinical trials as it can lead to more effective and safe treatments for this population. The exclusion of diverse populations from clinical research can result in a lack of understanding of how certain treatments may affect them differently, leading to potential harm or ineffective treatment. In addition, by including Arab ethnicities in clinical trials, researchers can gain valuable insight into the unique health needs and disparities of this population, leading to more tailored and effective healthcare solutions. Furthermore, it is a matter of equity and justice to ensure that all individuals have access to the same opportunities to participate in and benefit from medical research. By prioritizing diversity in clinical trials, we can work towards a more equitable healthcare system that serves all individuals, regardless of their race or ethnicity.